{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P84621",
      "entity_text" : "HDL-C",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9986" ],
      "TissueType" : [ "tissuelist:TS-0454" ],
      "CellType" : [ "cl:CL:0000581" ]
    }
  },
  "verbose_text" : "This study demonstrates that rosiglitazone, an anti-diabetic medication with potential anti-atherogenic activity, attenuates atherosclerosis, increases serum HDL-C levels and improves the anti-atherogenic functions of HDL in atherosclerotic rabbits.",
  "reading_complete" : "2020-08-03T16:55:29Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:54:20Z",
  "trigger" : "levels",
  "evidence" : [ "HDL-C levels" ],
  "pmc_id" : "4314417",
  "score" : 0
}